Body composition indices and cardiovascular risk in type 2 diabetes. CV biomarkers are not related to body composition

Body composition indices and cardiovascular risk in type 2 diabetes. CV biomarkers are not related to body composition

This study aims to explore the correlations of body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), waist-to-hip ratio (WHR) and body composition with levels of asymmetric dimethylarginine (ADMA), endothelin 1(ET-1), N-terminal brain natriuretic pro-peptide (NT-proBNP) and...

Full description

Bibliographic Details
Main Authors:	Markova Aleksandra, Boyanov Mihail, Bakalov Deniz, Tsakova Adelina
Format:	Article
Language:	English
Published:	De Gruyter 2020-04-01
Series:	Open Medicine
Subjects:	anthropometric indices nt-probnp asymmetric dimethylarginine endothelin-1 body composition analysis
Online Access:	https://doi.org/10.1515/med-2020-0043

Similar Items

Adaptive response triggered by the repeated SCUBA diving is reflected in cardiovascular, muscular, and immune biomarkers
by: Marko Žarak, et al.
Published: (2021-01-01)

Endothelin-1 serum levels in women with Rheumatoid Arthritis
by: Antonio Alvarez-Cienfuegos, et al.
Published: (2019-07-01)

The effect of metformin treatment on the level of GLP-1, NT-proBNP and endothelin-1 in patients with type 2 diabetes mellitus
by: L.K. Sokolova, et al.
Published: (2020-11-01)

The clinical value of determination of natriuretic peptides in acute coronary syndrome
by: Ekaterina Viktorovna Shreyder, et al.
Published: (2010-09-01)

Cardiac Biomarkers in Hyperthyroid Cats
by: Sangster, Jodi Kirsten
Published: (2014)

Importance of NT-pro BNP in the Prevention of Heart Failure, Left Ventricular Systolic Dysfunction and Cardiovascular Events
by: Irina CUCIUREANU, et al.
Published: (2021-06-01)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

ENDOTHELIAL DYSFUNCTIONS AND THEIR CORRECTION IN WOMEN WITH EARLY POSTMENOPAUSE
by: S. N. Tolstov, et al.
Published: (2017-05-01)

The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle
by: V V Kirillova, et al.
Published: (2018-09-01)

Levels of Biological Markers of Nitric Oxide in Serum of Patients with Mandible Fractures
by: Lukasz Wozniak, et al.
Published: (2021-06-01)

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis
by: Weiss NS, et al.
Published: (2021-04-01)

Associations between Endogenous Dimethylarginines and Renal Function in Healthy Children and Adolescents
by: Urszula Godula-Stuglik, et al.
Published: (2012-11-01)

Prognostic value of pathogenetic therapy-induced changes in NT-proBNP in patients with chronic heart failure
by: E M Mezhonov, et al.
Published: (2012-09-01)

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs
by: I G Kirillova, et al.
Published: (2016-05-01)

Serum Ürik Asit Düzeyinin Kardiyak Disfonksiyonda Prognostik bir Önemi Var mıdır?
by: Canan Topçuoğlu, et al.
Published: (2018-09-01)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
by: Zhu Q, et al.
Published: (2016-02-01)

Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
by: B. B. Samura
Published: (2017-12-01)

N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with coronary heart diseas
by: S V Shalaev, et al.
Published: (2009-05-01)

Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy
by: Karolina Weinmann, et al.
Published: (2019-10-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)

A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction
by: Li Hao, et al.
Published: (2020-07-01)

Relationship between N-terminal pro-B-type natriuretic peptide and renal function: the effects on predicting early outcome after off-pump coronary artery bypass surgery
by: Youn Yi Jo, et al.
Published: (2011-07-01)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD
by: Li H, et al.
Published: (2020-01-01)

Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients
by: Ewa Romuk, et al.
Published: (2020-01-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01)

NT-proBNP in Isolated Diastolic Dysfunction
by: Kenan İltümür, et al.
Published: (2005-01-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)

Utility of N-terminal pro-brain natriuretic peptide in detecting diastolic dysfunction in asymptomatic hypertensive patients: comparison with echocardiography
by: Sahadeb Prasad Dhungana, et al.
Published: (2019-03-01)

Changes in the Biomarkers of Oxidative/Nitrosative Stress and Endothelial Dysfunction Are Associated with Cardiovascular Risk in Periodontitis Patients
by: Nadia Ferlazzo, et al.
Published: (2021-07-01)

Asymmetric dimethylarginine as a prognostic marker for cardiovascular complications in hypertensive patients
by: Osama Tayeh, et al.
Published: (2011-06-01)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
by: Elif Torun Parmaksız, et al.
Published: (2018-01-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

The Indian Consensus Document on cardiac biomarker
by: I. Satyamurthy, et al.
Published: (2014-01-01)

The Usage of Heart Failure Biomarkers in China
by: Xinli Li, MD, PhD, et al.
Published: (2017-02-01)

Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015-12-01)

Propéptido natriurético tipo B N-terminal en adultos mayores ecuatorianos
by: Rubí Eliana Bermello Zamora, et al.
Published: (2020-01-01)

Evaluation of in-Hospital NT-ProBNP Changes in Heart Failure Patients to Identify the Six-Month Clinical Response Following Cardiac Resynchronization Therapy
by: Gholamreza Davoodi, et al.
Published: (2014-01-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)